Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
31 Agosto 2023 - 5:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will participate in the
upcoming Morgan Stanley 21st Annual Global Healthcare Conference in
New York, New York.
Guardant Health’s management is scheduled to participate in a
fireside chat on Monday, September 11, at 11:20 a.m. Eastern Time /
8:20 a.m. Pacific Time. Interested parties may access a live and
archived webcast of the presentation on the “Investors” section of
the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on helping conquer cancer globally through use of its proprietary
tests, vast data sets and advanced analytics. The Guardant Health
oncology platform leverages capabilities to drive commercial
adoption, improve patient clinical outcomes and lower healthcare
costs across all stages of the cancer care continuum. Guardant
Health has commercially launched Guardant360®, Guardant360® CDx,
Guardant360 TissueNext™, Guardant360 Response™, and
GuardantINFINITY™ tests for advanced-stage cancer patients, and
Guardant Reveal™ for early-stage cancer patients. The Guardant
Health screening portfolio, including the commercially launched
Shield™ test, aims to address the needs of individuals eligible for
cancer screening. For more information, visit guardanthealth.com
and follow the company on LinkedIn and Twitter (X).
Source: Guardant Health, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230831349385/en/
Investor Contact:
investors@guardanthealth.com
Media Contact:
press@guardanthealth.com
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024